Replies to post #523110 on NorthWest Biotherapeutics Inc (NWBO)

[FeMike]

These are all reasons why NWBO isn't a $10 billion dollar company right now.

Well, ya know, that, plus the fact that management hasn't updated its shareholders on their strategy for their only potential product in over 2 years. Could you imagine a scenario where a company whose management hasn't made a single statement on their lead investigational drug in over two years is doing well? Not likely.

But yeh, let's blame blue sky laws.

[Grip it and Sip It]

Let me respond to this:

or that they've decided to not talk about the stock given the risk to their career if they were wrong?

This is LAUGH OUT LOUD funny!! Didn't Merck assist with the trial and lend seasoned experts to NWBO to work with them. Wouldn't they know the data? Wouldn't they have enough info to make an informed decision on the data captured.

Crash- I really applaud your enthusiasm but let me offer you this: when in a hole, stop digging. You've twisted yourself into a knot looking for any narrative that contradicts the obvious.

Release the effin data and apply for approval. It's that simple.